Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Statement from HHS Secretary Kathleen Sebelius on the Reauthorization of Food and Drug Administration User Fee Programs


Location: Washington, DC

HHS applauds both houses of Congress for taking bipartisan action to reauthorize and expand the Food and Drug Administration user fee programs, building on recommendations developed by the FDA, along with consumer groups and pharmaceutical and medical device industries.

These programs ensure the FDA has the needed resources to conduct reviews of important medical products in a timely fashion, as well as provide new measures to improve the safety of the drug supply chain. Reauthorization encourages companies to continue to explore innovative new therapies and drug treatments. We look forward to working with both chambers as they resolve the differences between their two bills, so the good work of the FDA can continue.

Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top